Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Are There Ever Cases for More Frequent Dosing
Preclinical studies have shown that GIP may reduce body weight by reducing food intake and increasing energy consumption, and in combination with GLP-1 receptor agonists, may have a greater effect on patients' blood glucose and body weight
It is expected to become a new target for the treatment of metabolic disorders
Personalized advice on nutrition, exercise, and lifestyle adjustments
Alexander Shapsis describes this medication as a metabolic multi-tool. While existing drugs primarily focus on appetite, Retatrutide adds a direct fat-burning component
Limited access to GLP-1s in low-income and high-obesity regions threatens to widen existing health inequities, particularly in rates of diabetes, cardiovascular disease, and mobility-related conditions
US$ 27.63
US$ 22.07
US$ 28.76
US$ 25.27
US$ 29.16
US$ 25.52
US$ 20.93
US$ 27.45
US$ 23.25
US$ 22.81
